BindingDB logo
myBDB logout

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28283335 34 Discovery of selective ATP-competitive eIF4A3 inhibitors.EBI Takeda Pharmaceutical
29057054 29 Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1EBI Takeda Pharmaceutical
28358513 44 Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.EBI Takeda Pharmaceutical
28751196 46 Discovery of spiro[indole-3,2'-pyrrolidin]-2(1H)-one based inhibitors targeting Brr2, a core component of the U5 snRNP.EBI Takeda Pharmaceutical
28586220 27 Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.EBI Takeda California
10777579 12 Thermodynamic consequences of grafting enhanced affinity toward the mutated antigen onto an antibody. The case of anti-lysozyme antibody, HyHEL-10.BDB Tohoku University